menu
    • menu

    Company profile for AC Immune

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AC Immune’s leadership team combines a proven track record in entrepreneurial management and world-class scientific thought leadership. The team is committed to excellence and is passionate about delivering breakthrough therapies for neurodegenerative diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AC ImmuneSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    EPFL Innovation Park Building B 1015 Lausanne
    Telephone
    Telephone
    +41 21 345 91 21
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acimmune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AC Immune To Present At Jefferies 2025 London Health Conference
    AC Immune To Present At Jefferies 2025 London Health Conference

    12 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-12/ac-immune-to-present-at-the-jefferies-2025-london-healthcare-conference

    PHARMIWEB
    12 Nov 2025
    Share Share
    AC Immune To Present At Jefferies 2025 London Health Conference
    AC Immune To Present At Jefferies 2025 London Health Conference

    11 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-11/ac-immune-to-present-at-the-jefferies-2025-london-healthcare-conference

    PHARMIWEB
    11 Nov 2025
    Share Share
    AC Immune Appoints Name Neurologist Catherine to Advisory Board
    AC Immune Appoints Name Neurologist Catherine to Advisory Board

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175249/0/en/AC-Immune-Appoints-Renowned-Neurologist-Catherine-Mummery-as-Chair-of-Clinical-Advisory-Board.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    First Characterization of a TDP-43 PET Tracer Published in Nature
    First Characterization of a TDP-43 PET Tracer Published in Nature

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172823/0/en/First-Characterization-of-a-TDP-43-PET-Tracer-Published-in-Nature-Communications-Showing-Potential-of-AC-Immune-s-ACI-19626-in-Precision-Medicine.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    AC Immune's Anti-Ptau Immunotherapy Phase 1b/2a Trial Results
    AC Immune's Anti-Ptau Immunotherapy Phase 1b/2a Trial Results

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156158/0/en/Peer-reviewed-results-from-Phase-1b-2a-Trial-of-Anti-pTau-Active-Immunotherapy-from-AC-Immune-Published-in-eBioMedicine.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    AC Immune Reduces Workforce by 30%, Trims Pipeline
    AC Immune Reduces Workforce by 30%, Trims Pipeline

    04 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ac-immune-cuts-workforce-30-trims-pipeline-preserve-cash

    FIERCE BIOTECH
    04 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search